BIONIK Laboratories Corp, a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, announces that Dr. Eric Dusseux has resigned as Chief Executive Officer and stepped down from the board, to pursue an opportunity outside the rehabilitation robotic device industry.
The resignation is effective as of July 14, 2021. Rich Russo Jr., BIONIK’s current Chief Financial Officer, will assume the role of Interim CEO. The Board has begun a search for Dr. Dusseux’s successor, the company notes in a media release.
“This was a difficult decision that I reached after much reflection. It has been a privilege working as CEO, shoulder-to-shoulder with the best team in the business since September 2017. I am proud of all we have accomplished together to serve our patients and clients. I want to thank the team and the Board of Directors for their support.”
— Dr. Eric Dusseux
“On behalf of the Board, we thank Eric for his service and many accomplishments during his tenure as CEO, particularly during the COVID-19 pandemic. The company has made great strategic, commercial and operational progress under Eric’s leadership. We wish Eric the very best.”
“Eric has assembled a talented and highly capable leadership team, including Rich Russo, who will step in as Interim CEO. This will ensure continuity while we conduct a search for a permanent replacement.”
— André Auberton-Herve, Chairman of the Board
[Source(s): BIONIK Laboratories Corp, Business Wire]
Related Content:
InMotion Connect Data Analytics Solution: New from Bionik Labs
BIONIK Labs Partners with Intelliware to Collaborate on InMotion Connect
BIONIK Labs Debuts Updated InMotion System
